Company data
Acadia Pharmaceuticals Inc. employees and revenue per employee
ACAD · Biotechnology · $3.39B market cap
Acadia Pharmaceuticals Inc. had 653 employees at the end of fiscal Dec 2024, up 9.4% from a year earlier. Revenue for the year was $958M, up 31.8% from a year earlier, or $1.47M per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
653
+9.4% YoY
Revenue
$958M
+31.8% YoY
Revenue / employee
$1.47M
Peer median $459K
Rank in industry
20 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2024 | 653 | $958M | $1.47M | +9.4% | +31.8% |
| Dec 2023 | 597 | $726M | $1.22M | +16.8% | +40.4% |
| Dec 2022 | 511 | $517M | $1.01M | -0.2% | +6.8% |
| Dec 2021 | 512 | $484M | $946K | -14.8% | +9.6% |
| Dec 2020 | 601 | $442M | $735K | +19.5% | +30.3% |
| Dec 2019 | 503 | $339M | $674K | +17.0% | +51.5% |
| Dec 2018 | 430 | $224M | $520K | +1.2% | +79.2% |
| Dec 2017 | 425 | $125M | $294K | +14.9% | +620.7% |
| Dec 2016 | 370 | $17.3M | $47K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Acadia Pharmaceuticals Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | 293 | $868M | $2.96M | Efficient growth |
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| NVAX Novavax, Inc. | 749 | $1.12B | $1.50M | Leaner |
| ACAD Acadia Pharmaceuticals Inc. | 653 | $958M | $1.47M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| MDGL Madrigal Pharmaceuticals, Inc. | 915 | $958M | $1.05M | Efficient growth |
| IONS Ionis Pharmaceuticals, Inc. | 1,402 | $944M | $673K | Efficient growth |
| TECH Bio-Techne Corporation | 3,000 | $1.22B | $405K | Contracting |
| LEGN Legend Biotech Corporation | 2,900 | $1.03B | $355K | Efficient growth |
Questions about Acadia Pharmaceuticals Inc.
- How many employees does Acadia Pharmaceuticals Inc. have?
- Acadia Pharmaceuticals Inc. reported 653 employees for the fiscal year ending Dec 2024, in the annual report it filed on February 27, 2025. That is up 9.4% from a year earlier.
- What is Acadia Pharmaceuticals Inc.'s revenue per employee?
- Acadia Pharmaceuticals Inc. brought in $958M of revenue in fiscal Dec 2024, which is $1.47M per employee. That ranks 20 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare ACAD with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Acadia Pharmaceuticals Inc.'s annual reports (Form 10-K), latest filed February 27, 2025. This is data, not a recommendation to buy or sell ACAD.